Alec Stranahan

Alec Stranahan, Analyst Color, Analyst Ratings, Bank of America, Benzinga, BMG9456A1009, Eddie Lueng, Geoff Meacham, GLNG, GOSS, GWPH, Ken Hoexter, KYG814771047, Long Ideas, LX, NXTC, Price Target, Rodrigo Villanueva, SINA, Tazeen Ahmad, TIGO, Top stories, Trading Ideas

7 High-Risk Stocks For Market Gamblers

Casinos are just starting to open back up following COVID-19 shutdowns, but it may still be a while before some gamblers are willing to venture back to Vegas or even their local casino. Sports gamblers are still waiting for the return of Major League B…

Alec Stranahan, Analyst Color, Analyst Ratings, Bank of America, Benzinga, Biotech, Brian Abrahams, Coronavirus, COVID-19, General, Geoff Meacham, GILD, Gregory Renza, Health Care, Ivan Feinseth, Jim Birchenough, Matthew Harrison, morgan-stanley, Raymond James, RBC Capital, Reiteration, remdesivir, Sachin Jain, STAT, Steve Seedhouse, Tigress Financial, Top stories, US3755581036, wells fargo, Yanan Zhu

Gilead Analysts Tackle Early Results From Remdesivir Study In COVID-19, Morgan Stanley Says Stock Move Looks Overdone

Gilead Sciences, Inc. (NASDAQ: GILD) surged more than 16% after hours Thursday when STAT News reported promising preliminary results for a prospective COVID-19 thera

Latest Ratings for GILD
DateFirmActionFromTo Apr 2020CFRADowngradesHoldSell Apr 2…